Human immunoglobulin ameliorates rat experimental autoimmune neuritis

Brain

Volumn 120, Issue 9, 1997, Pages 1533-1540

  Gabriel, C M ^a,b   Gregson, N A ^a   Redford, E J ^a   Davies, M ^a   Smith, K J ^a   Hughes, R A C ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Demyelination; Experimental autoimmune neuritis; Immunoglobulin; IVIg; Polyneuropathy

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; MYELIN;

ALLERGIC NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT; REMYELINIZATION;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CATTLE; CAUDA EQUINA; HUMANS; IMMUNIZATION, PASSIVE; MALE; MICROSCOPY, ELECTRON; MYELIN SHEATH; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; SPINAL NERVE ROOTS;

EID: 0030765490     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.9.1533     Document Type: Article

References (29)

1. Achiron A, Margalit R, Hershkoviz R, Markovits D, Reshef T, Melamed E, et al. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. J Clin Invest 1994; 93: 600-5.
2. Basta M, Fries LF, Frank MM. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes. Blood 1991; 77: 376-80.
3. Enders U, Toyka KV, Hartung H-P, Gold R. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat. J Neuroimmunol 1997. In press.
4. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982; 306: 1254-8.
5. Hahn AF, Feasby TE, Wilkie L, Lovgren D. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis. Muscle Nerve 1993; 16: 1174-80.
6. Hurez V, Kaveri SV, Mouhoub A, Dietrich G, Mani JC, Klatzmann D, et al. Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. Ther Immunol 1994; 1: 269-77.
7. 198Au-colloid. Lymphology 1973; 6: 149-57.
8. Lowy I, Brezin C, Neauport-Sautes C, Theze J, Fridman WH. Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. Proc Natl Acad Sci USA 1983; 80: 2323-7.
9. Marchalonis JJ, Kaymaz H, Dedeoglu F, Schluter SF, Yocum DE, Edmundson AB. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain. Proc Natl Acad Sci USA 1992; 89: 3325-9.
10. Miyagi F, Horiuchi H, Nagata I, Kitahara S, Kiyoki M, Yuki N. Effects of intravenous immunoglobulin on experimental allergic neuritis [abstract]. Peripheral Nerve Society Meeting, Atlanta, Turkey. 1995.
11. Olin T, Saldeen T. The lymphatic pathways from the peritoneal cavity: a lymphangiographic study in the rat. Cancer Res 1964; 24: 1700-11.
12. 14C]adriamycin following intraperitoneal administration to rats. Cancer Res 1981; 41: 1311-7.
13. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré Syndrome. Lancet 1997; 349: 225-30.
14. Raine CS, Bornstein MB. Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest 1979; 40: 423-32.
15. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system [see comments]. Ann Neurol 1990; 27: 12-7. Comment in: Ann Neurol 1992; 32: 834-5.
16. Ronda N, Haury M, Nobrega A, Coutinho A, Kazatchkine MD. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg). Clin Immunol Immunopathol 1994; 70: 124-8.
17. Rossi F, Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989; 143: 4104-9.
18. Ruiz de Souza V, Carreno MP, Kaveri SV, Ledur A, Sadeghi H, Cavaillon JM, et al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 1995; 25: 1267-73.
19. Saida T, Saida K, Silberberg DH, Brown MJ. Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Nature 1978; 272: 639-41.
20. Saoudi A, Hurez V, de Kozak Y, Kuhn J, Kaveri SV, Kazatchkine MD, et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol 1993; 5: 1559-67.
21. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 84: 420-8.
22. Sultan Y, Rossi F, Kazatchkine MD. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci USA 1987; 84: 828-31.
23. van der Meché FG, Schmitz PI and the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome [see comments]. N Engl J Med 1992; 326: 1123-9. Comment in: N Engl J Med 1992; 327: 816.
24. van Doom PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1990; 291: 57-64.
25. van Engelen BGM, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M. Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis [Review]. J Neurol Neurosurg Psychiatry 1994; 57 Suppl: 65-8.
26. Vassilev T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkine MD. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol 1993; 92: 369-72.
27. Vedeler CA. Demonstration of Fc gamma receptors on human peripheral nerve fibres. J Neuroimmunol 1987; 15: 207-16.
28. Watts PM, Taylor WA, Hughes RAC. High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat. Exp Neurol 1989; 103: 101-4.
29. Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 1994; 125: 132-7.